INS and type 2 diabetes mellitus: Second, this phenomenon provides a mechanism accounting for the increase in plasma FGF21 concentration and hepatic FGF21 mRNA abundance observed in animals and patients with type 2 diabetes [64], [65], a condition that is associated with an elevation in the plasma concentration of both glucagon and insulin.